- Home
- CLB vs BCSF Comparison
CLB vs BCSF Comparison
Compare CLB & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CLB | BCSF |
|---|---|---|
| Founded | 1936 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 772.5M | 901.0M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CLB | BCSF |
|---|---|---|
| Price | $16.36 | $13.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $12.50 | ★ $15.50 |
| AVG Volume (30 Days) | 360.1K | ★ 381.8K |
| Earning Date | 01-28-2026 | 11-10-2025 |
| Dividend Yield | 0.24% | ★ 12.92% |
| EPS Growth | ★ 25.86 | N/A |
| EPS | 0.68 | ★ 1.44 |
| Revenue | ★ $517,501,999.00 | $278,347,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.33 | N/A |
| P/E Ratio | $24.06 | ★ $9.69 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.72 | $13.20 |
| 52 Week High | $20.82 | $19.21 |
Technical Indicators
Market Signals| Indicator | CLB | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 54.20 | 45.90 |
| Support Level | $15.97 | $13.68 |
| Resistance Level | $16.93 | $14.24 |
| Average True Range (ATR) | 0.51 | 0.23 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 42.94 | 26.67 |
Price Performance
Historical ComparisonAbout CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.